Literature DB >> 10379755

Activation of the kallikrein kinin system in interstitial cystitis.

A Rosamilia1, J A Clements, P L Dwyer, M Kende, D J Campbell.   

Abstract

PURPOSE: We investigated whether the kallikrein kinin system is activated in interstitial cystitis by measuring urinary excretion rates of kinin peptides, active and total kallikrein, and the kininase neutral endopeptidase in women with interstitial cystitis. We compared these excretion rates to a control group of women with stress incontinence and normal bladder function.
MATERIALS AND METHODS: Catheter urine was collected from subjects during a water diuresis (approximately 10 ml. per minute) before and after distention of the bladder with 100 ml. water. The contribution of the bladder wall to urinary kinins was assessed by measuring the change in kinin levels after 2 minutes of bladder stasis before and after distention.
RESULTS: Absolute bradykinin and kallidin excretion rates were similar in women with interstitial cystitis and control subjects. Two minutes of bladder stasis after bladder distention increased urinary bradykinin (p = 0.02) but not kallidin excretion rates. Active and total kallikrein excretion rates were similar in patients with interstitial cystitis and control subjects. Neutral endopeptidase excretion rates were reduced in the initial urine collection from subjects with interstitial cystitis but were similar in both groups during later collection periods.
CONCLUSIONS: These data provide evidence for increased bradykinin levels in the bladder wall of subjects with interstitial cystitis, which may be due in part to reduced neutral endopeptidase levels. These increased bradykinin levels may participate in the pathogenesis and symptomatology of interstitial cystitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379755     DOI: 10.1097/00005392-199907000-00030

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Changes in urine markers and symptoms after bladder distention for interstitial cystitis.

Authors:  Deborah R Erickson; Allen R Kunselman; Christina M Bentley; Kenneth M Peters; Eric S Rovner; Laurence M Demers; Marcia A Wheeler; Susan K Keay
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

Review 2.  Interstitial cystitis: the painful bladder syndrome.

Authors:  R Doggweiler-Wiygul; J Blankenship; S A MacDiarmid
Journal:  Curr Rev Pain       Date:  2000

Review 3.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

4.  Peptidomics analysis reveals changes in small urinary peptides in patients with interstitial cystitis/bladder pain syndrome.

Authors:  Md Shadman Ridwan Abid; Haowen Qiu; Bridget A Tripp; Aline de Lima Leite; Heidi E Roth; Jiri Adamec; Robert Powers; James W Checco
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

5.  Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium.

Authors:  Bikramjit Chopra; Stacey R Barrick; Susan Meyers; Jonathan M Beckel; Mark L Zeidel; Anthony P D W Ford; William C de Groat; Lori A Birder
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

6.  A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis.

Authors:  M Cervigni; F Natale; L Nasta; A Padoa; R Lo Voi; D Porru
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-13

7.  A Role for Bradykinin Signaling in Chronic Vulvar Pain.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Richard P Phipps
Journal:  J Pain       Date:  2016-08-18       Impact factor: 5.820

8.  Effect of inflammatory mediators on ATP release of human urothelial RT4 cells.

Authors:  Kylie J Mansfield; Jessica R Hughes
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.